feed,title,long_url,short_url
Benzinga,Polyphor Announces Closing of Fosun Pharma Licensing Agreement for balixafortide in China and Receipt of $15 Million Upfront Payment,https://www.benzinga.com/pressreleases/20/09/g17689111/polyphor-announces-closing-of-fosun-pharma-licensing-agreement-for-balixafortide-in-china-and-rece,https://j.mp/3cM6ldp
